|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
12 months to Feb 28, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net Loss | |||||
| Less: Earnings from discontinued operations, net of tax | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile loss from continuing operations to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Debt issuance costs | |||||
| Increase (decrease) in inventory reserves | |||||
| Provision for credit losses on accounts and notes receivable | |||||
| Asset impairment and store closure losses | |||||
| Gain on sale or disposal of property and equipment | |||||
| Expense recorded for stock compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Refundable income taxes | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Contract liabilities | |||||
| Net cash used in operating activities of continuing operations | |||||
| Net cash used in operating activities of discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Addition to notes receivable | |||||
| Repayments received on notes receivable | |||||
| Proceeds from insurance recovery | |||||
| Proceeds from the sale or distribution of assets | |||||
| Purchases of property and equipment | |||||
| Acquisition of company-owned store | |||||
| Increase in other assets | |||||
| Other | |||||
| Net cash used in investing activities of continuing operations | |||||
| Net cash provided by investing activities of discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Repurchase of common stock through net settlement of restricted stock units | |||||
| Proceeds from line of credit | |||||
| Dividends paid and redemption of outstanding preferred stock purchase rights | |||||
| Net cash (used in) provided by financing activities of discontinued operations | |||||
| Proceeds from notes payable | |||||
| Payment on line of credit | |||||
| Payment on notes payable | |||||
| Payment of debt issuance costs | |||||
| Stock issuance costs | |||||
| Issuance of common stock through securities purchase agreement | |||||
| Net cash provided by financing activities | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents, Beginning of Year | |||||
| Cash and Cash Equivalents, End of Year | |||||
Loading...